Skip to content

Public FDA record

Z-0264-2022: Permobil TiLite, Models: Aero Z, and ZRA

Recall record Z-0264-2022 for TiSport, Llc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0264-2022
Company in FDA record
TiSport, Llc
FDA record creation date
Nov 18, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Some affected wheelchairs, with transit tie downs, that are used as a passenger seat in a motor vehicle may not be configured in the right orientation to perform as intended if involved in a motor vehicle accident. Some affected wheelchairs can no longer be used as a passenger seat until transit tie downs are replaced with redesigned transit tie downs, verified, and released to the market.

Source facts

Action
On 09/24/21, distribution of correction notices started, via mail, to distributors. Distributors were advised the following: For AERO Z wheelchairs, the transit tie downs should have an inward orientation with transit bracket in rear most position. The wheelchair provider was provided with clear and thorough work instructions on how to inspect and, when necessary, correctly configure the transit tie downs. Stop using TiLite ZRA with transit tie downs as a passenger seat in a motor vehicle. Remove transit tie downs on TiLite ZRA wheelchairs. The recalling firm, if requested, will supply at no cost to the provider or the end-user an Aero Z with transit tie downs as a replacement for the ZRA. Once transit tie downs for the ZRA have been redesigned, verified, and released to the market, the updated transit tie downs will be provided, and the return of the replacement Aero Z will be coordinated. On October 1st, 2021, an update will be provided on our progress regarding the redesigned transit tie downs for ZRA wheelchair models. Customers with questions or concerns are encouraged to email tilite_quality@permobil.com or phone 800 736 0925, option 2. Distributors were advised that this market correction needs to be carried out at the consumer and end-user level. They were asked to immediately identify and contact their customer(s) with affected serial numbers. Distributor notification to customers may be more effective by including a copy of the end-user letter, which is attached with the distributor correction notice. If they are unable to contact the end-user or the transit tie downs/wheelchair are no longer available, please indicate this on the Serial Number Verification Form.
Initiated
2021-09-24
Root cause
Component change control
Distribution
US Nationwide Distribution: MD, PA, VA, IN, NY, MO, AR, NE, NJ, WA, NM, IL, CA, OH, KY, LA, OK, WI, TX, NC, SD, MN, MA, OR; OUS (Foreign): AUSTRALIA, CANADA, FRANCE, GERMANY, IRELAND, ITALY, UNITED KINGDOM, URUGUAY, NEW ZEALAND, IRELAND, SWEDEN
Recall number
Z-0264-2022
Recall status
Open, Classified
CDRH record ID
189394
FDA record created
2021-11-18
Recall event number
88718

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗